ARIAD Pharmaceuticals Recent News
Market Wrap For January 2: Markets Begin 2014 on Negative Note
Market Wrap For December 20: Markets Gain On GDP Data
Market Wrap For December 9: Investors Digest Further Clues Hinting at An Upcoming Taper
Market Wrap For November 25: Nasdaq Breaks 4,000 Level For First Time Since 2000
Market Wrap For November 22: Markets Finish The Week On a Positive Note
Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)
Best Biotech Stocks of 2011
J.P. Morgan Reiterates Overweight Rating On Ariad Pharmaceuticals
JP Morgan Raises PT On Ariad Pharmaceuticals To $13
Jefferies Provides Color on Ariad Pharmaceuticals, Buy
Brean Murray Raises PT on Aria Pharmaceuticals To $11
Ariad Pharmaceuticals Announces Its Phase 3 SUCCEED Trial Hits Primary Endpoint
Jefferies Raises PT On Ariad Pharmaceuticals
Ponatinib, A Key Driver For ARIAD Pharmaceuticals, Jefferies Reports